Baidu
map

Menopause:哪些因素影响绝经期潮热的安慰剂效应?

2017-09-07 王立群 环球医学

2017年8月,发表在《Menopause》的一项研究对绝经期潮热的安慰剂效应和相关因素进行了定量分析。研究表明,绝经期潮热的安慰剂效应与活性对照药物有关;在激素药物试验中观察到的反应率高于非激素药物试验。



2017年8月,发表在《Menopause》的一项研究对绝经期潮热的安慰剂效应和相关因素进行了定量分析。研究表明,绝经期潮热的安慰剂效应与活性对照药物有关;在激素药物试验中观察到的反应率高于非激素药物试验。

目的:本研究的目的是定量分析绝经期潮热的安慰剂效应和相关因素。

方法:在PubMed和Cochran数据库中检索报告绝经期潮热治疗的安慰剂对照试验,检索截止日期为2015年12月31日。从研究中提取参与者的临床特征和人口学特征和安慰剂效应,定义为与基线值相比每个观察时间点潮热减少的的百分比。基于模型的荟萃分析用于描述安慰剂效应的时间进程,并确定相关因素。

结果:分析纳入78篇文章中的85项试验,涉及8302名妇女。其中有47项试验涉及激素药物,37项涉及非激素药物,1项包括激素和非激素药物。研究结果表明,潮热的安慰剂效应以时间依赖性方式增加,并在第12周达到稳定。此外,在第24周,激素药物试验中的安慰剂效应显着高于非激素药物试验(-51.2%vs-40.4%;P<0.05),并且激素与非激素药物之间的差异与帕罗西汀效应相似。

结论:绝经期潮热的安慰剂效应与活性对照药物有关;在激素药物试验中观察到的反应率高于非激素药物试验。这些发现表明主观期望影响绝经期潮热的治疗效果。

原始出处:

Li L, et al. Quantitative analysis of placebo response and factors associated with menopausal hot flashes. Menopause. 2017 Aug;24(8):932-937. doi: 10.1097/GME.0000000000000858.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-09-09 ren1mw

    学习一下!谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-09-09 海豹
  5. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-09-07 1e0f8808m18(暂无匿称)

    更年期综合征治疗较难啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=242171, encodeId=4df82421e17b, content=学习一下!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Sat Sep 09 13:13:10 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257108, encodeId=cb9b125e108ae, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304340, encodeId=f80c1304340e9, content=<a href='/topic/show?id=81724580886' target=_blank style='color:#2F92EE;'>#安慰剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45808, encryptionId=81724580886, topicName=安慰剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cce318, createdName=wleon8895, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1304834, encodeId=ac351304834af, content=<a href='/topic/show?id=9b09e89052f' target=_blank style='color:#2F92EE;'>#绝经期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78905, encryptionId=9b09e89052f, topicName=绝经期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3289320, createdName=海豹, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461283, encodeId=e52d1461283c7, content=<a href='/topic/show?id=ec5966e3240' target=_blank style='color:#2F92EE;'>#潮热#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66732, encryptionId=ec5966e3240, topicName=潮热)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3db96414035, createdName=wodejia-dayu, createdTime=Sat Sep 09 10:51:00 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241538, encodeId=a0d62415382a, content=更年期综合征治疗较难啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Thu Sep 07 21:46:51 CST 2017, time=2017-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241512, encodeId=697f241512b2, content=学习一下!谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160916/IMG57DBEDBBA66BD2947.jpg, createdBy=3b181951777, createdName=ren1mw, createdTime=Thu Sep 07 19:56:46 CST 2017, time=2017-09-07, status=1, ipAttribution=)]
    2017-09-07 ren1mw

    学习一下!谢谢分享!

    0

相关资讯

Stroke:不同类型绝经期激素治疗的卒中风险分析!

在全国范围内,研究人员发现卒中风险增加,基于缺血性卒中,与口服激素治疗相关,与随机研究的结果相比较。该研究发现经皮应用不会增加卒中风险,并且阴道雌激素可以降低卒中的风险。

Diabet Med:绝经前雌激素水平低可增加未来患糖尿病的风险

本研究旨在研究绝经过渡期雌二醇与促卵泡激素水平的变化和糖尿病发生之间关联。研究随访了1047名基线年龄在42-52岁的绝经前妇女,均经历自然绝经。糖尿病的标准取决于空腹血糖水平,药物使用和内科医生诊断报告。使用用Cox比例风险回归评价糖尿病发生和激素变化率三大组成截距(绝经前水平)和两个分段斜率分别代表早期和晚期过渡期的变化。在15年的随访期间,132名女性发展为糖尿病。校正潜在混杂因素后,较高的

Menopause:论吸烟和绝经期对女性寿命的影响

发表在Menopause的一篇新进研究表明,鼓励女性戒烟还有另一个理由。这个由瑞典人进行的研究有25474名妇女参与,是第一个量化吸烟和绝经期对女性死亡率的综合影响的研究,在这过程中,吸烟是一个起促进作用的因素。已经证实,较早绝经会导致女性死亡率增加。在这项研究中,研究人员对众多瑞典女性进行了长达16年的研究和随访调查。研究表明,40岁绝经的女性比60岁绝经的女性死亡时间平均提早了1.3年。且研究

Sci Rep:高血压是否增加乳腺癌的发病风险?

目前,关于高血压与乳腺癌风险之间相关性的研究存在一定的矛盾。近期,一项发表在杂志Sci Rep上的研究进行了系统评价和荟萃分析,总结了有关高血压与乳腺癌风险之间的相关证据。通过对PubMed、EMBASE和Cochrane图书馆的综合文献检索,确定截至2016年8月的相关合格研究。此项荟萃分析包括报告了相对风险(RR)与相应95%置信区间(CI)的观察性研究。通过使用随机效应模型汇集个人研究结果。

Hum reprod update:子宫内膜异位病史的女性可不可以使用激素替代疗法治疗更年期综合征?

子宫内膜异位症被认为是一种典型的绝经前疾病,因为自然绝经或人为干扰绝经后随着雌激素水平的下降而自愈。然而,根据多年的病例报道发现绝经后子宫内膜异位症复发的概率增加。现已明确子宫内膜异位病灶复发和恶性转移均可发生在绝经期后。雌激素替代疗法(HRT)常用来治疗绝经期女性的更年期综合征和骨质丢失。现在很多人怀疑HRT可能会促进有子宫内膜异位症病史的女性子宫内膜异位症复发和子宫内膜发生恶性转移。鉴于HRT

Menopause:绝经期女性不适宜喝咖啡

2014 年 07 月 21 日在线发表在 Menopause 杂志上的一项横断面调查研究提示,摄入咖啡因与绝经期女性潮热、盗汗症状加重有关,但是,咖啡因也可减少绝经期女性情绪、记忆力和注意力方面的问题。该文章的第一作者,来自美国罗切斯特市梅奥诊所妇科保健门诊主任 Stephanie S. Faubion 教授指出,“虽然这只是初步结果,但是,我们的研究提示,限制咖啡因摄入对那些有潮热和盗汗症状的

Baidu
map
Baidu
map
Baidu
map